Cargando…
P53 and Survival Rate in Penile Cancer
BACKGROUND: Penile cancer accounts for 0.4-0.6% of all malignancy in men in Europe and the United States of America. It also accounts for 10% of all malignancy in men in some Asian, South American, and African countries. P53 protein has the function to regulate apoptosis in the cell cycle. Therefore...
Autores principales: | Prapiska, Fauriski Febrian, Warli, Syah Mirsya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Republic of Macedonia
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6490473/ https://www.ncbi.nlm.nih.gov/pubmed/31049102 http://dx.doi.org/10.3889/oamjms.2019.219 |
Ejemplares similares
-
Evaluation of Paclitaxel, Ifosfamide, and Cisplatin (TIP) Regimen on Penile Cancer in Adam Malik Medan: A Single Center 2 Years of Experience
por: Sitompul, Ardiansyah Periadi, et al.
Publicado: (2019) -
PCA3 and TMPRSS2: ERG Urine Level as Diagnostic Biomarker of Prostate Cancer
por: Warli, Syah Mirsya, et al.
Publicado: (2023) -
Systemic Inflammatory Response in Predicting Prostate Cancer: The Diagnostic Value of Neutrophil-To-Lymphocyte Ratio
por: Adhyatma, Kharisma Prasetya, et al.
Publicado: (2019) -
Association Between Interleukin-6 Levels and Lymph Node Metastasis in Bladder Cancer Patients
por: Warli, Syah Mirsya, et al.
Publicado: (2022) -
Tumor Markers as Predictors of Acute Kidney Injury Incidence and Staging of the Muscle-Invasive Bladder Cancer Receiving Chemoradiation Therapy
por: Warli, Syah Mirsya, et al.
Publicado: (2023)